Response to Orellano et al. regarding cost-utility analysis of dengue vaccination in a country with heterogeneous risk of dengue transmission

Vaccine. 2016 Jun 14;34(28):3222. doi: 10.1016/j.vaccine.2016.03.099.
No abstract available

Keywords: Argentina; Cost-utility analysis; Dengue; Dengue vaccines.

Publication types

  • Letter
  • Comment

MeSH terms

  • Cost-Benefit Analysis*
  • Dengue Vaccines
  • Dengue Virus / immunology
  • Dengue*
  • Humans
  • Risk
  • Vaccination

Substances

  • Dengue Vaccines